Interventional Treatment First for CLI

Size: px
Start display at page:

Download "Interventional Treatment First for CLI"

Transcription

1 Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075

2 Disclosures Consultant Cardiovascular Systems Inc, (CSI) Abbott Vascular Speaker AstraZeneca

3 Objectives Impact of Critical Limb Ischemia (CLI) Current guideline recommendations for CLI Who s getting revascularized What is the best initial strategy Angiosome guided revascularization Direct versus indirect revascularization

4 PAD Classification Schemes FONTAINE RUTHERFORD STAGE CLINICAL GRADE CATEGORY CLINICAL I Asymptomatic 0 0 Asymptomatic IIa Mild Claudication 0 1 Mild Claudication IIb Moderate/Severe I 2 Moderate III Rest Pain II, III 3 Severe IV Ulcer/Gangrene III 4 Rest pain 5 Minor tissue loss 6 Major tissue loss Gangrene

5 Critical Limb Ischemia is equivalent to a heart attack. It s the heart attack of the legs! - - Patrick Alexander

6 Impact of Critical Limb Ischemia (CLI) Peripheral Arterial Disease: Current Insight Into the Disease and Its Diagnosis and Management. Mayo Clin Proc. July 2010;85(7):

7

8 JACC Vol. 61, No. 14, /2011 Recommendations Class I indications for Tx of CLI

9 Trends in Endovascular Interventions, major amputation, and lower extremity bypass surgery, Goodney et al., 2009

10 Geographic Revascularization Rates - USA 2003 to 2006 Variation in the Use of Lower Extremity Vascular Procedures for Critical Limb Ischemia Goodney et al., Circ Cardiovasc Qual Outcomes. 2012;5:

11 Amputation without Vascular Evaluation Variation in the Use of Lower Extremity Vascular Procedures for Critical Limb Ischemia Goodney et al., Circ Cardiovasc Qual Outcomes. 2012;5:

12 Amputation First Approach EuroIntervention. May Vol 1;No 1;

13 Medicare Population: patients with at least one infrainguinal amputation identified (2.5 million patients) Analyzed clinical data and medical cost claims for 18 continuous months (12 month prior, 6 mo post) Treatment pathways PTA: Angioplasty IBS: Infrainguinal bypass graft PA: Primary amputation EuroIntervention. May Vol 1;No 1;

14 PA = 67% IBS = 23% PTA = 10% Initial Treatment & Outcomes Majority of wound complications (80%) and MI 7/9 (77.7%), stroke 13/16 (81.2%), and death 2/2 (100%) occurred in the PA group. Only 35% with an ABI and only 16% angiography before PA. EuroIntervention. May Vol 1;No 1; PA (primary amputation), IBS (infrainguinal bypass surgery), PTA (percutaneous transluminal angioplasty.

15 Today s Challenges Limited Randomized Controlled Trials Comparing Endovascular versus Surgical Revascularization Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial: Multicenter, randomized controlled trial. Lancet Dec 3,366(9501): CLI patients in UK (PTA vs. SB) à No change in amputation free survival

16 Best Endovascular versus Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST- CLI) Anticipated completion 2018 CLI patients with adequate aortoiliac inflow Candidate for either endovascular or surgical approach 4 arm study Endo vs surgery in those with available vein conduit Endo vs surgery in those with need for alternative conduit

17 Algorithmic Approach to the Patient with Critical Limb Ischemia Surgery Versus Endovascular Revascularization in the Critical Limb Ischemia Patient Scott EC., Endovascular Today. May 2015

18 Angiosome Concept Introduced in 1987 by Taylor and Palmer* Divided the body into three- dimension vascular territories supplied by specific source arteries and drained by specific veins. Foot and ankle with 6 distinct angiosomes arising from the PTA, ATA, and peroneal artery. *Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applicatons. Br J Plast Surg. 1987;40:

19 86 y/o male with right heel ulcer AT TPT AT DP

20 Direct versus Indirect Revascularization Improved wound healing and limb salvage when revascularization is delivered to the appropriate angiosome (regardless of the method). Wounds do not always correspond to a single discrete angiosome. Only 1/3 rd of CLI patients in recent study by Kret et al. 1, with lesion corresponding to a single angiosome. 1 J Vasc Surg.2014;59:

21 Catheterization and Cardiovascular Interventions 75: (2010) Retrospective analysis Rutherford 5 or patients (203 limbs)

22 86% 69% Patent runoff vessels after EVT Catheterization and Cardiovascular Interventions 75: (2010)

23 Conclusion Critical Limb Ischemia represents a small but critical percentage of patients with PAD [Save A Leg Save A Life * ]. Primary amputation strategy is not free of CV morbidity and mortality Endovascular Tx options continue to grow with development of specialized crossing catheters, alternative access sites, along with dedicated training programs for endovascular intervention. BEST CLI trial may offer further insight on current state of practice with regards to endovascular vs. surgical intervention. *Save A Leg Save A Life Foundation

24 Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Angiosome revascularization strategies in real world practice: how much difference does it make?

Angiosome revascularization strategies in real world practice: how much difference does it make? Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare

More information

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral

More information

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate

More information

3-year results of the OLIVE registry:

3-year results of the OLIVE registry: 3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure

More information

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology

More information

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Angiosome concept myth or truth? Does it make a real difference in real world cases? Angiosome concept myth or truth? Does it make a real difference in real world cases? Osamu Iida, MD, FACC Kansai Rosai Hospital Amagasaki, Hyogo, Japan Disclosure Speaker name:... I have the following

More information

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,

More information

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

PAD Characterization Within A Healthcare System RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016 PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler, MD September 14, 2016 Interventional Cardiology and Cath Labs Disclosures Research Grants: Agency for Healthcare Research

More information

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine Tulane

More information

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center

More information

LIMB SALVAGE IN THE DIABETIC PATIENT

LIMB SALVAGE IN THE DIABETIC PATIENT LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? DISCLOSURES Educational grant from Cook Inc OBJECTIVES Review risk stratification and staging schemes for the threatened limb Discuss current concepts

More information

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you

More information

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery

More information

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Rafael Malgor, MD Assistant Professor of Surgery The University of Oklahoma, Tulsa Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Background Lower extremity anatomy (below the

More information

BEST-CLI Trial Study Concept and Current Status

BEST-CLI Trial Study Concept and Current Status BEST-CLI Trial Study Concept and Current Status Kenneth Rosenfield, MD, MHCDS National Co-PI BEST-CLI Trial Section Head, Vascular Medicine and Intervention Institute for Heart, Vascular, and Stroke Care

More information

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study -

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - Shinya Sasaki, MD. Saka General Hospital Miyagi, JAPAN Disclosure

More information

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott -

More information

Peripheral arterial disease for primary care Ed Aboian, MD

Peripheral arterial disease for primary care Ed Aboian, MD Peripheral arterial disease for primary care Ed Aboian, MD Division of Vascular and Endovascular Surgery Palo Alto Medical Foundation, Burlingame Ca Disclosures Nothing to disclose Clinical presentation

More information

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care Michael S. Conte MD Professor and Chief, Division of Vascular and Endovascular

More information

Current Status of Endovascular Therapies for Critical Limb Ischemia

Current Status of Endovascular Therapies for Critical Limb Ischemia Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu

More information

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott

More information

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb

More information

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage George L. Adams, MD, MHS, MBA, FACC, FSCAI Clinical Associate Professor of Medicine University of North Carolina Health System Director

More information

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009 Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting

More information

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) W. Schuyler Jones, MD FACC Director, Adult Cardiac Catheterization Laboratory

More information

Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.

Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D. Lower Extremity Peripheral Arterial Disease: Its All About the Pulse Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity

More information

SAVE LIMBS SAVE LIVES!

SAVE LIMBS SAVE LIVES! SAVE LIMBS SAVE LIVES! PAD Awareness: The Key to Limb Preservation By Frank J Tursi, D.P.M., F.A.C.F.A.S. Epidemiology Over 12 million people are afflicted with PAD 11 Million of these-dm 4 Million DFU

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following

More information

Treatment Strategies For Patients with Peripheral Artery Disease

Treatment Strategies For Patients with Peripheral Artery Disease Treatment Strategies For Patients with Peripheral Artery Disease Presented by Schuyler Jones, MD Duke University Medical Center & Duke Clinical Research Institute AHRQ Comparative Effectiveness Review

More information

Specificities for infrapopliteal stents

Specificities for infrapopliteal stents Specificities for infrapopliteal stents Nicolas Diehm, M.D. Swiss Cardiovascular Center Clinical and Interventional Angiology University Hospital Bern, Switzerland Disclosures Speaker`s Bureau: MEDRAD,

More information

THERE IS NO PROOF FOR THE ANGIOSOME CONCEPT

THERE IS NO PROOF FOR THE ANGIOSOME CONCEPT THERE IS NO PROOF FOR THE ANGIOSOME CONCEPT Peter Huppert Professor of Radiology and Neuroradiology Department of Radiology, Neuroradiology and Nuclear Medicine Klinikum Darmstadt Academic Teaching Hospital

More information

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have

More information

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA... 1 CONCLUSION... 9 U.S. CRITICAL LIMB ISCHEMIA PREVALENCE... 9 MARKET OPPORTUNITY ENDOVASCULAR... 9 MARKET OPPORTUNITY

More information

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Vascular and Endovascular Management in Diabetic Vasculopathy Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery

More information

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE Michael S. Conte MD Professor and Chief, Vascular and Endovascular Surgery Co-Director, Center for Limb Preservation Co-Director, Heart and Vascular

More information

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

Clinical Approach to CLI and Related Diagnostics: What You Need to Know Clinical Approach to CLI and Related Diagnostics: What You Need to Know Ido Weinberg, MD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital None Disclosures Critical

More information

Are DES and DEB worth the cost in BTK interventions?

Are DES and DEB worth the cost in BTK interventions? Are DES and DEB worth the cost in BTK interventions? Thomas Zeller, MD University Heart-Center Freiburg-Bad Krozingen Bad Krozingen, Germany -1- My Disclosures: Advisory Board: Medtronic-Invatec, Gore,

More information

Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58

Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Marc P. Bonaca MD MPH for the DECLARE TIMI 58 Investigators American College of Cardiology March 2019

More information

Registry Assessment of Peripheral Interventional Devices (RAPID)

Registry Assessment of Peripheral Interventional Devices (RAPID) Registry Assessment of Peripheral Interventional Devices (RAPID) Adding Data Sources May 2, 2018 W. Schuyler Jones, MD Duke Clinical Research Institute Duke Heart Center Disclosures Research Grants: Agency

More information

OMNIA case results: Lumee Oxygen measurements representative for CLI wound healing prognosis. M Werner 1 Feb 2018

OMNIA case results: Lumee Oxygen measurements representative for CLI wound healing prognosis. M Werner 1 Feb 2018 OMNIA case results: Lumee Oxygen measurements representative for CLI wound healing prognosis M Werner 1 Feb 2018 Disclosure Speaker name:... I have the following potential conflicts of interest to report:

More information

Critical Limb Ischemia: Diagnosis and Current Management

Critical Limb Ischemia: Diagnosis and Current Management Research Article Joseph Karam, MD Elliot J. Stephenson, MD From: Minneapolis Heart Institutet at Abbott Northwestern Hospital, Minneapolis, MN Address for correspondence: Joseph Karam, MD Minneapolis Heart

More information

SPINACH Making Limb Salvage Salad from Spinach alone

SPINACH Making Limb Salvage Salad from Spinach alone SPINACH Making Limb Salvage Salad from Spinach alone Surgical reconstruction versus Peripheral Intervention in patients with critical limb ischemia prospective multicenter registry in Japan Nobuyoshi Azuma,

More information

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge L E I P Z I G I N T E R V E N T I O N A L C O U R S E 2017 Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge Markus Haumer Landesklinikum Baden-Mödling

More information

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan COI disclosure Disclosure Speaker name: Taku Kato... I have the

More information

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE

More information

Making the difference with Live Image Guidance

Making the difference with Live Image Guidance Live Image Guidance 2D Perfusion Making the difference with Live Image Guidance In Peripheral Arterial Disease Real-time results, instant assessment Severe foot complications the result of hampered blood

More information

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012 Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD

More information

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D. Lower Extremity Peripheral Arterial Disease: Less is Sometimes More Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity

More information

Practical Point in Diabetic Foot Care 3-4 July 2017

Practical Point in Diabetic Foot Care 3-4 July 2017 Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University

More information

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff P. Kuryanov, A. Lipin, A. Antropov, K. Atmadzas, A. Atmadzas, Y. Eminov, A. Borisov, R. Sobolev, A.Orlov Limb

More information

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan Olive registry: 3-years outcome of BTK intervention in Japan Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan What is the optimal treatment for the patient with critical limb ischemia (CLI)?

More information

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons What's New on the Vascular Horizons? NCVH New Cardiovascular Horizons KNOW YOUR OPTIONS Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans,

More information

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Practical Point in Holistic Diabetic Foot Care 3 March 2016 Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai

More information

Guidelines for Management of Peripheral Arterial Disease

Guidelines for Management of Peripheral Arterial Disease Guidelines for Management of Peripheral Arterial Disease Subhash Banerjee, MD, FACC, FSCAI Professor of Medicine, Univ. of Texas Southwestern Medical Center Chief, Division of Cardiology, VA North Texas

More information

Perfusion Assessment in Chronic Wounds

Perfusion Assessment in Chronic Wounds Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,

More information

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have

More information

Peripheral Vascular Disease

Peripheral Vascular Disease Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of

More information

Fluorescent Angiography: Practical uses in the Clinical Setting

Fluorescent Angiography: Practical uses in the Clinical Setting Fluorescent Angiography: Practical uses in the Clinical Setting Charles Andersen MD, FACS, MAPWCA Chief Vascular/Endovascular/ Limb Preservation Surgery Service (Emeritus) Chief of Wound Care Service Madigan

More information

Peripheral Arterial Disease: the growing role of endovascular management

Peripheral Arterial Disease: the growing role of endovascular management Peripheral Arterial Disease: the growing role of endovascular management Poster No.: C-1931 Congress: ECR 2012 Type: Educational Exhibit Authors: E. M. C. Guedes Pinto, E. Rosado, D. Penha, P. Cabral,

More information

Now That You Have the Tools

Now That You Have the Tools blockosu@gmail.com Now That You Have the Tools Alan Jay Block, DPM, MS, FASPS, FACFAS Assistant Professor Dept Of Orthopeadics The Ohio State University Medical Board Kent State University Editor-in -Chief

More information

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts Dr Steven Kum MBBS MMed FRCS FAMS Vascular & Endovascular Surgeon Vascular Centre Department of Surgery Changi

More information

Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4

Lower Extremity Revascularization D oes Anesthesia Matter. Onaona Gurney PGY 4 Lower Extremity Revascularization D oes Anesthesia Matter Onaona Gurney PGY 4 Case Presentation 89yoM PMH of HTN, DM, HLD, BPH presented to podiatry with abscess to R great toe 5 weeks prior Drained by

More information

Clinical use and safety of the Lutonix DCB for the treatment of BTK: interim data from a prospective registry

Clinical use and safety of the Lutonix DCB for the treatment of BTK: interim data from a prospective registry Clinical use and safety of the Lutonix DCB for the treatment of BTK: interim data from a prospective registry Alexander Zimmermann Department of Vascular and Endovascular Surgery Klinikum rechts der Isar

More information

6/12/2014. Peripheral Arterial Disease US Population. Defining CLI and the Scope of the Problem. Defining CLI and the Scope of the Problem

6/12/2014. Peripheral Arterial Disease US Population. Defining CLI and the Scope of the Problem. Defining CLI and the Scope of the Problem 6/12/2014 Defining CLI and the Scope of the Problem Defining CLI and the Scope of the Problem Barry T. Katzen, MD Founder and Executive Medical Director Clinical Professor of Radiology and Surgery FIU

More information

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? Ehrin J. Armstrong, MD MSc MAS Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare

More information

Vascular Protection in Patients with CAD and PAD: New Options

Vascular Protection in Patients with CAD and PAD: New Options Vascular Protection in Patients with CAD and PAD: New Options Professor Dr Eike Sebastian Debus Direktor Klinik für Gefäßmedizin Gefäßchirurgie Angiologie Interventionelle Therapie Deutsches Aortenzentrum

More information

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene

More information

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular Intercepting PAD Playbook for Cardiovascular Care 2018 February 24, 2018 Jonathan D Woody, MD, FACS University Surgical Vascular Attending Vascular Surgeon - Piedmont Athens Regional Adjunct Clinical Associate

More information

Update on BEST-CLI Trial

Update on BEST-CLI Trial Update on BEST-CLI Trial Alik Farber, M.D. Professor and Chief Division of Vascular and Endovascular Surgery Boston Medical Center Boston University School of Medicine Disclosures Trial Co-Chair Supported

More information

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center UCSF Medical

More information

Evidence-Based Optimal Treatment for SFA Disease

Evidence-Based Optimal Treatment for SFA Disease Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular

More information

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of referenced technologies as well as current standards of care

More information

The Final Triumph Of Endovascular Therapy In SFA Treatment

The Final Triumph Of Endovascular Therapy In SFA Treatment The Final Triumph Of Endovascular Therapy In SFA Treatment MEET 07 Mark W. Mewissen, M.D. Director, St Lukes Vascular Center Milwaukee, WI Endovascular Therapy In SFA Treatment: Works In Progress! Mark

More information

Use of Laser In BTK Disease (CLI)

Use of Laser In BTK Disease (CLI) Use of Laser In BTK Disease (CLI) Click to edit academic affiliation, practice or hospital logo(s) of preference. Product and/or sponsor logos not permitted, per CME guidelines. Richard Kovach, MD, FACC,

More information

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller One Year after In.Pact Deep: Lessons learned from a failed trial Prof. Dr. Thomas Zeller Disclosure Speaker name: Thomas Zeller... I have the following potential conflicts of interest to report: x Consulting:

More information

The Burden of CLI and Crosser Catheter Recanalization Strategies

The Burden of CLI and Crosser Catheter Recanalization Strategies , LLC an HMP Communications Holdings Company November 2013 Volume 25/ Supplement D www.invasivecardiology.com The Official Journal of the International Andreas Gruentzig Society The Burden of CLI and Crosser

More information

All endovascular interventions carry the risk of

All endovascular interventions carry the risk of Prevention and Management of CLI Complications Interventionists must be aware of and prepared to treat complications that can occur during endovascular treatment of high-risk lesions. BY ANDREW HOLDEN,

More information

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015

Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015 Ron Fairman, MD Vice-President of the Society for Vascular Surgery MedCAC 2015 Ron Fairman, MD No Disclosures The SVS represents more than 5,000 practicing vascular surgeons across the US. The nation s

More information

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Osamu Iida, MD From the Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan. ABSTRACT: Approximately

More information

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS LIBBY WATCH, MD MIAMI VASCULAR SPECIALISTS MIAMI CARDIAC & VASCULAR INSTITUTE FINANCIAL DISCLOSURES None 2

More information

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) (Angiolite BTK DES, IVascular) P. Goverde MD, K. Taeymans MD, K. Lauwers MD Vascular Clinic ZNA Antwerp,Belgium

More information

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Surgical Options for revascularisation P E T E R S U B R A M A N I A M Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation

More information

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of

More information

LUTONIX DCB in BTK Update on the BTK clinical program & single center experience

LUTONIX DCB in BTK Update on the BTK clinical program & single center experience LUTONIX DCB in BTK Update on the BTK clinical program & single center experience Prof. Dr. med. Dierk Scheinert Department of Interventional Angiology University Hospital Leipzig Disclaimer 1. The information

More information

Claudication Exercise vs. Endoluminal Revascularization

Claudication Exercise vs. Endoluminal Revascularization Claudication Exercise vs. Endoluminal Revascularization Anthony J. Comerota, MD, FACS, FACC Director, Jobst Vascular Institute Adjunct Professor of Surgery, University of Michigan Disclosures NIH Research

More information

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert LINC 2016, Leipzig Surgical Bypass or A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist Wouter Van den Eynde OLV Hospital,

More information

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August Introduction to Peripheral Arterial Disease Stacey Clegg, MD Interventional Cardiology August 20 2014 Outline (and for the ABIM board exam * ** ***) Prevalence* Definitions Lower Extremity: Aorta*** Claudication***

More information

DON T LET LEG PAIN BECOME A REAL THREAT.

DON T LET LEG PAIN BECOME A REAL THREAT. DON T LET LEG PAIN BECOME A REAL THREAT. These three words have the power to change lives. Between 8 to 10 million Americans are estimated to suffer from poor blood flow to the legs and feet potentially

More information

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification

Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification Clasificación WIFI: Finalmente hablaremos el mismo idioma! WIfI: Wound, Ischemia, foot Infection The SVS Threatened Limb Classification Joseph L. Mills, Sr., M.D. Professor of Surgery, Chief, Vascular

More information